[HTML][HTML] Home monitoring in interstitial lung diseases

MS Wijsenbeek, CC Moor, KA Johannson… - The Lancet …, 2023 - thelancet.com
The widespread use of smartphones and the internet has enabled self-monitoring and more
hybrid-care models. The COVID-19 pandemic has further accelerated remote monitoring …

Home monitoring for patients with ILD and the COVID-19 pandemic

G Nakshbandi, CC Moor… - The Lancet Respiratory …, 2020 - thelancet.com
The current COVID19 pandemic has challenged the continuity of health care and research.
Healthcare providers around the world are required to deal with social distancing and …

A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease

TM Maher, C Schiffman, M Kreuter, CC Moor… - Respiratory …, 2022 - Springer
Background Patients with interstitial lung disease (ILD) require regular physician visits and
referral to specialist ILD clinics. Difficulties or delays in accessing care can limit opportunities …

Managing threats to respiratory health in urban slums

W Checkley, SL Pollard, T Siddharthan… - The Lancet …, 2016 - thelancet.com
More than half the world's population lives in urban areas, and an estimated 863 million
people currently live in urban slums. 1 Although urbanisation is usually coupled with …

Chronic respiratory diseases: a global view

WW Labaki, MLK Han - The Lancet Respiratory Medicine, 2020 - thelancet.com
Chronic respiratory diseases are among the most common non-communicable diseases
worldwide, largely due to the ubiquity of noxious environmental, occupational, and …

Use of bronchoalveolar lavage to assess the respiratory microbiome: signal in the noise

HL Twigg, A Morris, E Ghedin, JL Curtis… - The lancet Respiratory …, 2013 - thelancet.com
In 2007, the US National Institutes of Health added the Human Microbiome Project to the
National Institutes of Health Roadmap for Medical Research. The lung—traditionally thought …

Susceptibility to exacerbation in COPD

JR Hurst, A Anzueto, J Vestbo - The Lancet Respiratory Medicine, 2017 - thelancet.com
We welcome the report by the SPIROMICS investigators in The Lancet Respiratory
Medicine, 1 repeating our 2010 ECLIPSE analysis2 describing exacerbations in chronic …

Treatable traits in interstitial lung diseases: a call to action

F Amati, P Spagnolo, JM Oldham… - The Lancet …, 2023 - thelancet.com
Comment 126 www. thelancet. com/respiratory Vol 11 February 2023 therefore be
amenable to similar treatment strategies. 1, 2 This evidence points to the existence of …

Home monitoring in patients with idiopathic pulmonary fibrosis. A randomized controlled trial

CC Moor, RLM Mostard, JC Grutters… - American journal of …, 2020 - atsjournals.org
Rationale: Idiopathic pulmonary fibrosis (IPF) is a deadly disease with increasingly impaired
health-related quality of life (HRQOL). eHealth technologies facilitate collection of …

Overdiagnosis in lung cancer screening

MEJ Callister, P Sasieni, HA Robbins - The Lancet Respiratory …, 2021 - thelancet.com
Overdiagnosis in cancer screening is the detection of cancers that would not have become
clinically apparent if the person had not been screened. Diagnosis of cancer causes anxiety …